Entrar/Registro  
INICIO ENGLISH
 
Annals of Hepatology
   
MENÚ

Contenido por año, Vol. y Num.

Índice de este artículo

Información General

Instrucciones para Autores

Mensajes al Editor

Directorio






>Revistas >Annals of Hepatology >Año 2006, No. 3


López-Méndez E, Chávez-Tapia NC, Avila-Escobedo L, Cabrera-Aleksandrova T, Uribe M
Early experience of Budd-Chiari syndrome treatment with transjugular intrahepatic portosystemic shunt
Ann Hepatol 2006; 5 (3)

Idioma: Inglés
Referencias bibliográficas: 17
Paginas: 157-160
Archivo PDF: 130.70 Kb.


Texto completo




FRAGMENTO

Sin resumen


Palabras clave: Sin palabras Clave


REFERENCIAS

  1. Janssen HL, García-Pagan JC, Elias E, Mentha G, et al. Budd-Chiari syndrome: a review by an expert panel. J Hepatol 2003; 38: 364-71.

  2. Senzolo M, Cholongitas EC, Patch D, Burroughs AK. Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 182-190.

  3. Okuda K, Kage M, Shrestha SM. Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion. Hepatology 1998; 28: 1191-1198.

  4. Hadengue A, Poliquin M, Vilgrain V, Belghiti J, Degott C, Erlinger S, et al. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 1994; 106: 1042-1047.

  5. Murad SD, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EB, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 2004; 39: 500-508.

  6. Zeitoun G, Escolano S, Hadengue A, Azar N, El Younsi M, Mallet A, et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 1999; 30: 84-89.

  7. McCarthy PM, van Heerden JA, Adson MA, Schafer LW, Wiesner RH. The Budd-Chiari syndrome. Medical and surgical management of 30 patients. Arch Surg 1985; 120: 657-662.

  8. Mancuso A, Fung K, Mela M, Tibballs J, Watkinson A, Burroughs AK, et al. TIPS for acute and chronic Budd-Chiari syndrome: a singlecentre experience. J Hepatol 2003; 38: 751-754.

  9. Perello A, Garcia-Pagan JC, Gilabert R, Suarez Y, Moitinho E, Cervantes F, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology 2002; 35: 132-139.

  10. Hernandez-Guerra M, Turnes J, Rubinstein P, Olliff S, Elias E, Bosch J, et al. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology 2004; 40: 1197-1202.

  11. Ahn SS, Yellin A, Sheng FC, Colonna JO, Goldstein LI, Busuttil RW. Selective surgical therapy of the Budd-Chiari syndrome provides superior survivor rates than conservative medical management. J Vasc Surg 1987; 5: 28-37.

  12. Menon KV, Shah V, Kamath P. Budd-Chiari syndrome. New England Journal of Medicine 2004; 350: 578-85.

  13. Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E. Favourable medium term outcome following hepatic vein recanalization and/or TIPS for Budd Chiari syndrome. Gut 2006; 55: 878-84.

  14. Molmenti EP, Segev DL, Arepally A, Hong J, Thuluvath PJ, Rai R, et al. The utility of TIPS in the management of Budd-Chiari syndrome. Ann Surg 2005; 241: 978-981.

  15. Khuroo MS, Al-Suhabani H, Al-Sebayel M, Al Ashgar H, Dahab S, Khan MQ, et al. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol 2005; 20: 1494-1502.

  16. Sanyal A, Genning C, Reddy KR, Wong F, et al. The North American Study for the Treatment of Refractory Ascites. Gastroenterology 2003; 124: 634-631.

  17. Boyer T, Haskal Z. The Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension. Hepatology 2005; 41: 386-400.



>Revistas >Annals of Hepatology >Año2006, No. 3
 

· Indice de Publicaciones 
· ligas de Interes 






       
Derechos Resevados 2019